TELA Bio (TELA) Competitors $1.08 -0.09 (-7.69%) Closing price 04:00 PM EasternExtended Trading$1.10 +0.02 (+1.85%) As of 04:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TELA vs. ELMD, PROF, LAKE, INGN, DRTS, AVR, BWAY, SKIN, OBIO, and TLSIShould you be buying TELA Bio stock or one of its competitors? The main competitors of TELA Bio include Electromed (ELMD), Profound Medical (PROF), Lakeland Industries (LAKE), Inogen (INGN), Alpha Tau Medical (DRTS), Anteris Technologies Global (AVR), BrainsWay (BWAY), Beauty Health (SKIN), Orchestra BioMed (OBIO), and TriSalus Life Sciences (TLSI). These companies are all part of the "medical equipment" industry. TELA Bio vs. Electromed Profound Medical Lakeland Industries Inogen Alpha Tau Medical Anteris Technologies Global BrainsWay Beauty Health Orchestra BioMed TriSalus Life Sciences TELA Bio (NASDAQ:TELA) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, risk, valuation, dividends, community ranking, analyst recommendations, earnings and institutional ownership. Which has better valuation & earnings, TELA or ELMD? Electromed has lower revenue, but higher earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTELA Bio$69.30M0.66-$46.66M-$1.39-0.84Electromed$59.63M3.38$5.15M$0.7531.44 Do analysts rate TELA or ELMD? TELA Bio presently has a consensus price target of $7.25, suggesting a potential upside of 519.66%. Electromed has a consensus price target of $38.00, suggesting a potential upside of 61.15%. Given TELA Bio's higher probable upside, research analysts plainly believe TELA Bio is more favorable than Electromed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TELA Bio 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Electromed 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Is TELA or ELMD more profitable? Electromed has a net margin of 11.34% compared to TELA Bio's net margin of -60.49%. Electromed's return on equity of 15.71% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets TELA Bio-60.49% -556.18% -63.13% Electromed 11.34%15.71%13.37% Does the MarketBeat Community favor TELA or ELMD? TELA Bio received 38 more outperform votes than Electromed when rated by MarketBeat users. However, 91.67% of users gave Electromed an outperform vote while only 74.07% of users gave TELA Bio an outperform vote. CompanyUnderperformOutperformTELA BioOutperform Votes6074.07% Underperform Votes2125.93% ElectromedOutperform Votes2291.67% Underperform Votes28.33% Does the media refer more to TELA or ELMD? In the previous week, TELA Bio had 2 more articles in the media than Electromed. MarketBeat recorded 3 mentions for TELA Bio and 1 mentions for Electromed. Electromed's average media sentiment score of 0.72 beat TELA Bio's score of 0.05 indicating that Electromed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TELA Bio 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Electromed 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, TELA or ELMD? TELA Bio has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Comparatively, Electromed has a beta of 0.41, meaning that its share price is 59% less volatile than the S&P 500. Do institutionals and insiders hold more shares of TELA or ELMD? 94.3% of TELA Bio shares are held by institutional investors. Comparatively, 40.8% of Electromed shares are held by institutional investors. 6.0% of TELA Bio shares are held by insiders. Comparatively, 14.0% of Electromed shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryElectromed beats TELA Bio on 12 of the 19 factors compared between the two stocks. Remove Ads Get TELA Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TELA vs. The Competition Export to ExcelMetricTELA BioSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$46.08M$4.28B$5.53B$7.50BDividend YieldN/A37.84%4.86%4.05%P/E Ratio-0.6928.6923.2318.08Price / Sales0.6645.73362.7586.83Price / CashN/A51.0838.1634.64Price / Book1.525.906.493.99Net Income-$46.66M$67.64M$3.21B$247.18M7 Day Performance-5.26%-4.92%-4.90%-4.25%1 Month Performance-50.00%-4.68%-0.07%-6.87%1 Year Performance-77.80%9.68%6.45%-3.73% TELA Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TELATELA Bio2.3585 of 5 stars$1.08-7.7%$7.25+571.3%-77.9%$42.54M$69.30M-0.64120High Trading VolumeELMDElectromed0.9223 of 5 stars$24.45-1.1%$38.00+55.4%+52.8%$209.22M$59.63M32.60160Gap DownPROFProfound Medical2.0151 of 5 stars$6.81flat$14.25+109.3%-36.1%$204.57M$10.68M-5.08150LAKELakeland Industries4.5898 of 5 stars$21.09+12.4%$28.33+34.3%+0.4%$200.33M$151.82M-234.331,800Upcoming EarningsGap DownHigh Trading VolumeINGNInogen2.3174 of 5 stars$7.37+0.3%$7.00-5.0%+1.6%$195.53M$335.71M-3.281,030DRTSAlpha Tau Medical1.9662 of 5 stars$2.70+3.4%$8.00+196.3%-14.5%$188.80MN/A-6.2880AVRAnteris Technologies GlobalN/A$5.12-1.2%$16.50+222.3%N/A$184.44M$2.71M0.00138Gap DownHigh Trading VolumeBWAYBrainsWay2.9149 of 5 stars$9.77-1.4%$13.17+34.8%+61.6%$183.94M$41.02M97.71120Gap DownSKINBeauty Health1.6507 of 5 stars$1.41+7.6%$2.50+77.3%-66.1%$175.01M$334.29M-3.361,030Positive NewsOBIOOrchestra BioMed1.51 of 5 stars$4.57+1.3%$15.40+237.0%-36.5%$173.72M$2.65M-2.844Earnings ReportAnalyst ForecastNews CoverageGap DownTLSITriSalus Life Sciences3.3176 of 5 stars$5.67+0.5%$11.56+103.9%-46.6%$172.90M$26.89M-2.28106High Trading Volume Remove Ads Related Companies and Tools Related Companies Electromed Competitors Profound Medical Competitors Lakeland Industries Competitors Inogen Competitors Alpha Tau Medical Competitors Anteris Technologies Global Competitors BrainsWay Competitors Beauty Health Competitors Orchestra BioMed Competitors TriSalus Life Sciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TELA) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TELA Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TELA Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.